Azora Therapeutics is a clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists. Our team has decades of experience in drug development and has helped develop groundbreaking medicines for patients, including Uceris®, Tysabri®, Ycanth® and Humira®.